Chloroquine serum concentration and side effects: evidence for dose-dependent kinetics

Area of Science:

• Rheumatology
• Clinical Pharmacology

Background:

• Rheumatoid arthritis (RA) is a chronic autoimmune disease.
• Chloroquine is used in RA treatment.
• Understanding drug pharmacokinetics is vital for patient safety.

Purpose of the Study:

• To investigate the relationship between serum chloroquine concentrations and side effects in RA patients.
• To explore the pharmacokinetic profile of chloroquine in RA patients.
• To determine if total administered dose correlates with serum levels or side effects.

Main Methods:

• Serum chloroquine levels were measured using fluorometry.
• 100 RA patients receiving 0.25 gm daily for at least 2 months were studied.
• Data on total dose, annual dose, and observed side effects were collected.

Main Results:

• 15% of patients experienced side effects.
• A correlation was found between serum chloroquine concentrations and side effects.
• No significant relationship was observed between total administered dose and side effects.
• Chloroquine exhibited dose-dependent kinetics.

Conclusions:

• Serum chloroquine levels, not total dose, are linked to adverse effects in RA patients.
• Monitoring chloroquine serum concentrations can help ensure safe and effective treatment.
• Dose-dependent kinetics suggest individual variability in chloroquine metabolism and elimination.